68

RBC Bioscience Corporation

6848 · TWO · Healthcare / Biotechnology

20.95TWD+0.05 (+0.24%)

Price History

Full chart

Market Stats

Previous Close20.90
Open20.20
Day Range20.20 – 20.95
52-Week Range11.77 – 25.75
Volume3.01K
Market Cap271.90M
P/E (TTM)15.43
Forward P/E0.00
EPS1.39
Dividend Yield23.47%
Beta0.46
50-Day Avg21.34
200-Day Avg18.86

About

RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis. It offers robotic bench-top workstation for nucleic acid purification under the MagCore Plus II and Giga Automated Nucleic Acid Extractor names; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment. The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. It has operations in Taiwan, rest of Asia, Africa, the United States, and internationally. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Mingwei Zhuo
  • Employees50
  • HeadquartersNo. 15, Qiaohe Road, New Taipei City, Taiwan, 235029, Taiwan
  • Websitehttps://www.rbcbioscience.com

Leadership

  • Mr. Mingwei ZhuoChairman & GM
  • Ms. Sulan FangAccountant & Accounting Supervisor
  • Mr. Yen-Liang ChenDeputy General Manager of Manufacturing Department
  • Mr. Kexin ZhanDeputy General Manager of Management Office
  • Mr. Zhengwei WeiDirector of R&D

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue161.68M575.16M251.18M173.89M172.47M205.25M
Growth (%)-+255.74%-56.33%-30.77%-0.82%+19.01%
Cost of Revenue94.78M274.84M134.11M100.89M99.57M107.17M
Gross Profit66.90M300.33M117.07M73.01M72.89M98.07M
Gross Margin41.38%52.22%46.61%41.98%42.27%47.78%
Operating Expense47.38M111.94M68.46M65.26M58.36M62.27M
Operating Income19.52M188.38M48.61M7.75M14.54M35.80M
Operating Margin12.07%32.75%19.35%4.46%8.43%17.44%
EBITDA24.85M192.87M62.31M32.12M36.55M54.83M
EBITDA Margin15.37%33.53%24.81%18.47%21.19%26.71%
Net Income14.46M141.90M28.73M3.78M6.43M21.57M
Net Income Margin8.94%24.67%11.44%2.17%3.73%10.51%
R&D8.79M22.24M16.39M15.74M10.84M9.86M
R&D as % of Total Revenue5.44%3.87%6.53%9.05%6.28%4.80%
Interest Expense1.01M1.18M6.33M7.57M10.00M10.30M
Interest Expense % of Total Revenue0.62%0.21%2.52%4.36%5.80%5.02%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets200.95M512.62M847.60M790.55M753.79M763.88M-
Total Liabilities27.16M337.89M590.77M541.73M513.08M514.58M-
Total Equity87.73M174.73M256.83M248.81M240.71M249.30M-
Cash43.26M123.94M97.47M75.93M65.18M79.86M-
Total Debt94.83M120.47M510.99M481.75M471.64M478.47M-
Net Debt51.57M97.59M449.27M428.53M422.19M398.61M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow40.16M205.68M-25.30M6.60M13.21M55.93M
Investing Cash Flow-9.94M-119.50M-425.67M12.61M1.00M-9.37M
Financing Cash Flow-8.90M-5.49M424.49M-40.75M-24.96M-31.88M
Capital Expenditure9.08M118.41M450.12M10.05M6.46M10.32M
Free Cash Flow31.07M87.27M-475.42M-3.44M6.74M45.61M
Dividends Paid12.28M54.76M14.38M11.80M14.53M12.97M
FCF to OCF77.38%42.43%1879.18%-52.16%51.06%81.54%
Dividend Paid to FCF39.51%62.75%-3.02%-342.51%215.50%28.45%

Key Statistics & Ratios

Market Cap271.90M
Enterprise Value661.69M
Trailing P/E15.43
Forward P/E0.00
Price / Sales1.40
Price / Book1.13
EPS1.39
Book Value18.22
Revenue (TTM)220.60M
Gross Profit (TTM)101.59M
EBITDA41.04M
Profit Margin9.55%
Operating Margin9.42%
Return on Equity8.09%
Return on Assets2.26%
Shares Outstanding14.27M
Shares Float8.07M
Beta0.46
Dividend Yield23.47%
Dividend Rate5.03
Payout Ratio21.58%

Dividends

20262×
3.53Sep 2, 20261.20Jul 9, 2026
20251×
0.30Oct 2, 2025
20242×
0.51Sep 19, 20240.40Aug 5, 2024
20231×
1.02Jul 13, 2023
20221×
0.91Jul 21, 2022

Stock Splits

  • Aug 11, 20251100:1000
  • Jul 21, 20221100:1000